More Than Access
More Than Access (MTA) S.r.l. Società Benefit is a boutique consulting firm specialized in providing services that facilitate market access for healthcare technologies. MTA is founded upon the idea of building healthy partnerships with scientific societies, Institutions and academia, patient associations and companies offering complementary services and is oriented to the European context through the development of strategic collaborations with agencies in other countries
Based on the knowledge of the target market and the analysis of its continuous evolution, MTA intends to offer customized solutions to support all stakeholders in the drug supply chain and in particular pharmaceutical companies-whether Big Pharma or start-ups-in order to optimize the access of health technologies up to the patient, in an effective, timely and sustainable way.
events
archivio
PHARMATREND 2025
Early Access Progams: it’s time for a new deal DATA: 12-13 Marzo 2025 SEDE: Park Hotel Villa Ferrata (Grottaferrata – RM) RESPONSABILE SCIENTIFICO: Armando Genazzani, Professore di Farmacologia, Dipartimento di Scienze e Tecnologia del Farmaco, Università degli Studi...
COMBOCONNECT 2025
Bridging Access Gaps in Combination Therapies DATA: 26 Marzo 2025 SEDE: Istituto Luigi Sturzo – Palazzo Baldassini, Via delle Coppelle 35, Roma RESPONSABILI SCIENTIFICI: Proff. Pier Luigi Canonico e Claudio Jommi Evento di presentazione del Report, realizzato in...
HEALTHforFUTURE 2025
Rethinking the healthcare system through discussing past and current issues DATA: 26-27 giugno 2025 SEDE: Mantova – Ca’ Uberti Palace Hotel RESPONSABILE SCIENTIFICO: Paola Minghetti, Professoressa di Tecnologia e Legislazione Farmaceutiche e Direttore Dipartimento di...
archivio
HEALTHforFUTURE 2024
Shaping Healthcare from Education to Business DATA: 17-18 giugno 2024 SEDE: Hotel NH Bergamo RESPONSABILE SCIENTIFICO: Paola Minghetti, Professore di Tecnologia e Legislazione Farmaceutiche e Direttore Dipartimento di Scienze Farmaceutiche, Facoltà di Scienze del...
Our firm is based on solid values
oriented toward excellence in consulting.
Boutique consulting firm
We are proud to be a boutique consulting firm, as it allows us to offer a highly personalized and dedicated service to our clients. This enables us to fully understand their specific needs and provide tailored, quick and creative solutions that generate added value.
Client orientation
We always make the client the focus of everything we do. We listen carefully to requests, needs and ambitions, and analyze everything critically, to develop strategies and action plans until we deliver the best possible solution, always creating partnerships based on mutual trust.
Community value
Siamo costantemente impegnati a migliorare, anche tramite attività di ricerca e/o non profit, lo stato di salute dei pazienti e la sostenibilità del Servizio Sanitario Nazionale, promuovendo, sostenendo e rendendo possibile l’avvio di iniziative destinate a creare valore nella comunità e ad avere un impatto positivo in termini di utilità sociale.
Business ethics
We are proud to be a Benefit Corporation, which emphasizes our commitment to maintaining a positive impact on the community. Our consulting is based on ethical principles and a responsible approach, which allows us to operate with integrity, transparency and respect for all parties involved.
MTA Code of Ethics
Model of Organization, Management and Control pursuant to D.Lgs. 231/2001
Certificazioni
More Than Access Srl Società Benefit è certificata UNI PdR 125:2022 Sistema di gestione per la parità di genere
We are focused and oriented on creating the best possible conditions for inclusiveness, flexibility and quality of work, to attract, grow and retain talents, enhancing their skills and aptitudes, not only exquisitely job-related ones, favoring the use of innovative and technological solutions aimed at implementing a work-life integration approach.
We are focused and oriented on creating the best possible conditions for inclusiveness,
flexibility and quality of work, to attract, grow and retain talents, enhancing their skills and aptitudes, not only exquisitely job-related ones, favoring the use of innovative and technological solutions aimed at implementing a work-life integration approach.
meet the team
Dario Lidonnici | Founder & Managing Director
Giorgio Casilli | Co-Founder & Market Access Lead
Giorgio is an experienced Market Access professional with a solid academic background (Master's Degree in Pharmacy, 2nd Level Master's Degree in Regulatory Disciplines and Market Access in Pharmaceuticals). Over the years, Giorgio has rapidly progressed in his career, providing strategic advice and detailed analysis for numerous projects in multiple therapeutic areas. His expertise has also been established through a strong research interest by authoring scientific articles and participating in conferences, proving his commitment to in-depth, continuous professional development and knowledge sharing in the field. The combination of his academic education, professional experience, and commitment to scientific research make Giorgio a passionate and qualified professional, ready to bring a fresh and innovative perspective.
Armando Isernia | Regional Market Access Director
Decades of experience in the pharmaceutical world, with increasing responsibilities in the areas of sales and access, in a multinational company. After several years as Head of Regional Market Access at AstraZeneca, since July 2012 he has taken on the role of Regional Market Access Director & Partner at MA Provider, dealing with both access consultancy and staff training for pharmaceutical and device companies. During his career, Armando has also been a lecturer in various training courses in different masters.
Roberto Ravasio | HEOR and RWE Lead
Roberto has more than two decades of experience in the field of Market Access, Health Economics and Outcomes Research, Pharmacoeconomics, Health Technology Assessment. Roberto developed specific skills in cost-effectiveness analysis, budget impact analysis, drug utilization analysis, real world data analysis, Delphi Panel, strategic consultancy and training. Roberto has also been a lecturer in various training courses in different masters. Roberto is the co-Editor of Global & Regional Health Technology Assessment and the Editor of AboutOpen magazine HTA section. He is currently HEOR & RWE Lead at MTA.
Aureliano Stingi | Senior Project Manager
Aureliano is a cancer biologist and science communication expert with a diverse background in oncology, ranging from basic research to clinical applications.
Aureliano contributing regularly as a scientific journalist for Repubblica, where he covers topics such as COVID-19, aging, and health. He has hosted several health-focused podcasts in collaboration with leading pharmaceutical companies.
With a PhD in Cancer Biology and an MBA, Aureliano combines his scientific expertise with a deep understanding of the medical market, making him informed in both the research and business aspects of healthcare.
Marika De Nigris | Market Access Manager
Marika has a master’s degree in Healthcare Management. After initial work experiences at Sanofi and Boston Scientific, Marika decided to develop her attitude towards consultancy, joining a first leading healthcare consulting firm and then MTA with the role of Market Access Manager. After four years of experience, Marika is able to deal with complex projects, directly interacting with KOLs, payers and clients, and managing the whole execution of P&R dossiers in different therapeutic areas.
Andrea Torriani | Market Access Manager
Andrea holds a master’s degree in Pharmaceutical Chemistry and Technology and demonstrated an early passion for market access consultancy. He joined a leading healthcare consulting firm during his academic path, first performing his master thesis project and then starting his professional career. With over three years of substantial experience in the field, Andrea has assumed the role of Market Access Manager at MTA. Here, he continues the play an integral part in numerous successful projects spanning several therapeutic areas.
Federica Maiocchi | Market Access Manager
With a Master of Science degree in Management, Federica began her professional journey focusing on innovation and Health Technology Assessment within an Italian hospital group. She subsequently gained three years of experience at a leading healthcare consultancy, where she deepened her expertise in market access and reimbursement, participating in strategic projects at the European, national, and regional levels.
She has now joined MTA as a Market Access Manager, where she is committed to advance the adoption of innovative therapies by engaging with Key Opinion Leaders and contributing to the development of sustainable, value-driven access strategies.
Alessia Dinoia | Market Access Specialist
Alessia holds a degree in Pharmaceutical Chemistry and Technology and during her studies had a brief experience as a pharmacist and oncology researcher. She later earned a 2nd Level Master’s Degree in Healthcare Management, Pharma and Biomed.
After a two years experience in a consulting firm in Life Science and Healthcare, now with passion and enthusiasm, she joins such as Market Access Specialist.
Edoardo Sanna | Market Access Specialist
Edoardo holds a degree in Pharmacy and a 2nd Level Master’s Degree in Market Access and Regulatory Disciplines. After gaining experience as a pharmacist and consultant in the Lifescience sector, he now serves as a Market Access Specialist at MTA.
His skill in finding innovative solutions to complex situations, along with his curiosity and drive for continuous improvement, motivates him to contribute with dedication to the success of the projects he works on.
Tommaso Cao | Market Access Specialist
Tommaso holds a master’s degree in Pharmaceutical Chemistry and Technology from the University of Piemonte Orientale. After graduating, he began his career at the Clinical Trial Center of the Hospital “Maggiore della Carità” in Novara, where he was responsible for contract negotiations and documentation management for clinical trials.
Nell’aprile 2024, Tommaso si è unito a MTA per ampliare le sue conoscenze nell’ambito del market access, frequentando inoltre un Master di II livello in Discipline Regolatorie e Accesso al Mercato, per consolidare ulteriormente la sua expertise.
Manuel Karim Chaaoub | Market Access Specialist
Driven by a growing interest in pharmaceutical access policies, he oriented his career toward market access. In November 2025, he joined MTA as a Market Access Specialist.
Muriel Bertomoro | Business Support Manager
Muriel has more than 15 years experience in the administrative and organizing fields.
After an initial 3-years experience in the commercial-marketing field, Muriel worked for 12 years for the Italian Society of Pharmacology and the Italian Society of Toxicology, both non-profit associations in the medical-scientific field, covering the roles of Administrative, Associates and Fundraising Manager.
She currently holds the role of Business Support Manager at MTA.
meet the team
Dario Lidonnici | Founder & Managing Director
Dario ha un’esperienza ultradecennale nel campo del market access ed è un professionista oggi riconosciuto in Italia e all’estero. Formazione scientifica ed economica di primo e secondo livello, Dario è apprezzato dai clienti e dagli stakeholder per la professionalità, il carisma e la conoscenza del settore e dei suoi attori. L’approccio pragmatico e la visione strategica sono le caratteristiche antitetiche che gli consentono di condurre progettualità creative e di successo e che è impegnato a trasmettere ai professionisti più giovani.
Dario mantiene infatti stretti legami con il mondo accademico, condividendo la sua conoscenza e le sue competenze in diversi corsi di formazione.
Giorgio Casilli | Co-Founder & Market Access Lead
Giorgio is an experienced Market Access professional with a solid academic background (Master's Degree in Pharmacy, 2nd Level Master's Degree in Regulatory Disciplines and Market Access in Pharmaceuticals). Over the years, Giorgio has rapidly progressed in his career, providing strategic advice and detailed analysis for numerous projects in multiple therapeutic areas. His expertise has also been established through a strong research interest by authoring scientific articles and participating in conferences, proving his commitment to in-depth, continuous professional development and knowledge sharing in the field. The combination of his academic education, professional experience, and commitment to scientific research make Giorgio a passionate and qualified professional, ready to bring a fresh and innovative perspective.
Armando Isernia | Regional Market Access Director
Decades of experience in the pharmaceutical world, with increasing responsibilities in the areas of sales and access, in a multinational company. After several years as Head of Regional Market Access at AstraZeneca, since July 2012 he has taken on the role of Regional Market Access Director & Partner at MA Provider, dealing with both access consultancy and staff training for pharmaceutical and device companies. During his career, Armando has also been a lecturer in various training courses in different masters.
Roberto Ravasio | HEOR and RWE Lead
Roberto has more than two decades of experience in the field of Market Access, Health Economics and Outcomes Research, Pharmacoeconomics, Health Technology Assessment. Roberto developed specific skills in cost-effectiveness analysis, budget impact analysis, drug utilization analysis, real world data analysis, Delphi Panel, strategic consultancy and training. Roberto has also been a lecturer in various training courses in different masters. Roberto is the co-Editor of Global & Regional Health Technology Assessment and the Editor of AboutOpen magazine HTA section. He is currently HEOR & RWE Lead at MTA.
Aureliano Stingi | Senior Project Manager
Aureliano is a cancer biologist and science communication expert with a diverse background in oncology, ranging from basic research to clinical applications.
Aureliano contributing regularly as a scientific journalist for Repubblica, where he covers topics such as COVID-19, aging, and health. He has hosted several health-focused podcasts in collaboration with leading pharmaceutical companies.
With a PhD in Cancer Biology and an MBA, Aureliano combines his scientific expertise with a deep understanding of the medical market, making him informed in both the research and business aspects of healthcare.
Marika De Nigris | Market Access Manager
Marika has a master’s degree in Healthcare Management. After initial work experiences at Sanofi and Boston Scientific, Marika decided to develop her attitude towards consultancy, joining first Pharmalex (formerly MA Provider) and then MTA with the role of Market Access Manager. After four years of experience, Marika is able to deal with complex projects, directly interacting with KOLs, payers and clients, and managing the whole execution of P&R dossiers in different therapeutic areas.
Andrea Torriani | Market Access Manager
Andrea holds a master’s degree in Pharmaceutical Chemistry and Technology and demonstrated an early passion for market access consultancy. He joined Pharmalex (formerly MA Provider) during his academic path, first performing his master thesis project and then starting his professional career. With over three years of substantial experience in the field, Andrea has assumed the role of Market Access Manager at MTA. Here, he continues the play an integral part in numerous successful projects spanning several therapeutic areas.
Federica Maiocchi | Market Access Manager
With a Master of Science degree in Management, Federica began her professional journey focusing on innovation and Health Technology Assessment within an Italian hospital group. She subsequently gained three years of experience at a leading healthcare consultancy, where she deepened her expertise in market access and reimbursement, participating in strategic projects at the European, national, and regional levels.
She has now joined MTA as a Market Access Manager, where she is committed to advance the adoption of innovative therapies by engaging with Key Opinion Leaders and contributing to the development of sustainable, value-driven access strategies.
Alessia Dinoia | Market Access Specialist
Alessia holds a degree in Pharmaceutical Chemistry and Technology and during her studies had a brief experience as a pharmacist and oncology researcher. She later earned a 2nd Level Master’s Degree in Healthcare Management, Pharma and Biomed.
After a two years experience in a consulting firm in Life Science and Healthcare, now with passion and enthusiasm, she joins such as Market Access Specialist.
Edoardo Sanna | Market Access Specialist
Edoardo holds a degree in Pharmacy and a 2nd Level Master’s Degree in Market Access and Regulatory Disciplines. After gaining experience as a pharmacist and consultant in the Lifescience sector, he now serves as a Market Access Specialist at MTA.
His skill in finding innovative solutions to complex situations, along with his curiosity and drive for continuous improvement, motivates him to contribute with dedication to the success of the projects he works on.
Tommaso Cao | Market Access Specialist
Tommaso holds a master’s degree in Pharmaceutical Chemistry and Technology from the University of Piemonte Orientale. After graduating, he began his career at the Clinical Trial Center of the Hospital “Maggiore della Carità” in Novara, where he was responsible for contract negotiations and documentation management for clinical trials.
Nell’aprile 2024, Tommaso si è unito a MTA per ampliare le sue conoscenze nell’ambito del market access, frequentando inoltre un Master di II livello in Discipline Regolatorie e Accesso al Mercato, per consolidare ulteriormente la sua expertise.
Manuel Karim Chaaoub | Market Access Specialist
Manuel holds a Master’s Degree in Health Biology from the University of Siena, where he developed a strong interest in the healthcare sector. He further strengthened his expertise by completing a Master’s program in Management for the Healthcare, Pharma and Biomedical fields, gaining solid knowledge of regulatory processes, organizational models and market access dynamics.
Driven by a growing interest in pharmaceutical access policies, he oriented his career toward market access. In November 2025, he joined MTA as a Market Access Specialist.
Muriel Bertomoro | Business Support Manager
Muriel has more than 15 years experience in the administrative and organizing fields.
After an initial 3-years experience in the commercial-marketing field, Muriel worked for 12 years for the Italian Society of Pharmacology and the Italian Society of Toxicology, both non-profit associations in the medical-scientific field, covering the roles of Administrative, Associates and Fundraising Manager.
She currently holds the role of Business Support Manager at MTA.
01 Market Access Plan
We develop targeted strategies for healthcare technology market access, with due consideration for the dynamics of the specific field and especially the patients' needs.
02 Negotiation strategy
We provide support in establishing effective negotiation strategies to achieve suitable pricing & reimbursement in line with client expectation.
03 Stakeholder mapping
We identify and engage key players in the field, such as regulatory authorities, payers, and patient associations, in order to create strategic partnerships and maximize market access opportunities.
01 P&R dossier drafting
With expertise in drafting several P&R dossiers in multiple therapeutic areas, we are among the top experts in Pricing & Reimbursement dossier drafting ensuring an accurate and persuasive presentation of the product's value proposition to obtain approval and reimbursement at the best conditions.
02 Regional dossier drafting
We support the creation of region-specific dossiers, considering local peculiarities and the needs of the relevant authorities.
03 Advisory board management
We organize and manage national and regional advisory boards in order to gain valuable insights and obtain qualified feedback from engaged experts.
04 Stakeholder engagement
We actively manage relationships with industry KOLs, facilitating dialogue and collaboration to achieve shared results.
Training
We provide customized training programs for companies and healthcare professionals to deepen their knowledge in the areas of Market Access, Pricing & Reimbursement, and Health Technology Assessment (HTA).
Events
We organize events focused on market access and related topics, such as conferences, workshops and webinars, which provide opportunities to learn from the best minds in the industry, share experiences and networking.
Beyond Access: our impact on Environment,
Sustainability and Governance
Read More
ESG – Environment, Sustainabilty, Govarnance
At More Than Access, we integrate environment, people and governance into every project.
We believe that high-quality consulting must go hand in hand with sustainable practices, inclusion, and transparency.
- Environment: we reduce our impact and promote sustainable choices.
- People: we put people at the center, fostering inclusion and diversity.
- Governance: we act with integrity, responsibility, and transparency.
Our ESG commitment aims to create real value for the community, making sustainability and ethics an integral part of our growth.
Gender Equality
We firmly believe that gender equality is a core value and an essential driver of our success, innovation and social impact. We are committed to creating an inclusive, fair and respectful work environment, where everyone has equal opportunities for growth, development and professional fulfillment, regardless of gender. This policy reflects our ongoing commitment to gender equality and aligns with our Code of Ethics, our focus on environmental and social sustainability, and our attention to employee well-being.
Ethics and Transparency
Our consultancy is grounded in ethical principles and a responsible approach, enabling us to operate with integrity, transparency and respect for all stakeholders involved.
The Organizational Model was established with the aim of preventing unlawful conduct through a clear system of rules, controls and procedures applied to the activities most exposed to risk. Together with the Code of Ethics, these documents serve as a concrete point of reference to guide the conduct of employees, collaborators and partners, strengthening a culture of legality and responsibility.
Model of Organization, Management and Control pursuant to D.Lgs. 231/2001
Environment and Sustainability
To advance our objectives as a Benefit Corporation, MTA decided to measure our environmental impact in a concrete way, starting with the development of our GHG inventory (Greenhouse Gas Protocol Corporate Accounting and Reporting Standard). This tool enables us to calculate and monitor all our greenhouse gas emissions, categorizing them by Scope 1, 2, and 3, so that we can identify where to take the most effective actions.
Sustainability is an integral part of our growth strategy: we will continue to invest in transparency, accountability and innovation to generate long-term value.
EcoVadis
EcoVadis is the leading international platform that assesses companies’ sustainability performance, analyzing various areas including environment, human rights, ethics and sustainable procurement.
MTA has recently completed the assessment process conducted by EcoVadis, achieving a Silver Scorecard.
This recognition confirms the strength of our commitment to environmental, ethical, human rights, and responsible procurement issues, demonstrating the adoption of practices and processes aimed at the responsible and sustainable management of our activities.
Performance di Sostenibilità – Ecovadis
Science Based Targets initiative (SBTi)
MTA has defined a clear and concrete pathway toward climate sustainability, based on the guidelines of the Science Based Targets initiative (SBTi).
Through the accurate measurement of our emissions profile, we have developed a sustainability strategy, identifying the areas where actions are needed to reduce our environmental impact. As a result of this process, we have submitted an emissions reduction target to SBTi, aligned with science-based objectives to limit the rise in global temperatures.
This milestone represents a measurable and transparent commitment for us, forming part of an ongoing journey to continuously improve our environmental performance.
Carbon Credits
In accordance with the procedures of the Science Based Targets initiative (SBTi), for indirect emissions that are harder to reduce in the short term (Scope 3), we have opted for offsetting through the purchase of certified carbon credits, thereby supporting environmental projects that contribute to CO₂ reduction or removal.
research projects
In MTA, crediamo di poter dare il nostro contributo all’avanzamento della conoscenza e, pertanto, collaboriamo con esperti del settore e istituzioni accademiche per condurre studi originali, contribuendo attivamente alla crescita della comunità scientifica e alla promozione della ricerca indipendente.
In this section you will find a collection of our research work, including publications, reports, abstracts, and posters presented at national and international Congresses.
01Publication
Casilli G, Lidonnici D, Jommi C, De Nigris M, Genazzani AA. Do France, Germany, and Italy agree on the added therapeutic value of medicines? International Journal of Technology Assessment in Health Care. 2023;39(1):e54. doi:10.1017/S026646232300048X
Report
COMBOCONNECT – Bridging Access Gaps in Combination Therapies, Marzo 2025
02Report
EARLY ACCESS PROGRAM: TRA CRITICITÀ E PROPOSTE PER IL FUTURO – Rapporto per ISPOR Italy Rome Chapter, DICEMBRE 2023
03Poster
Lidonnici D, Casilli G, De Nigris M, Torriani A, 50(+1) SFUMATURE DI… INNOVATIVITÀ, Presented at Convegno Nazionale ISPOR ITALY – ROME CHAPTER 12-13 DICEMBRE 2023
MTA as a boutique consulting firm stands out for direct accessibility and building strong partnerships with clients. Our distinctive feature is a streamlined approach and direct involvement in each project, providing extensive experience and recognized expertise to ensure customized, high-level consulting services. We do not simply provide standardized solutions but create tailored strategies that reflect our clients' business realities. We are dedicated to supporting our clients not only for specific projects, but for long-term success in the Market Access field.
With an eye on creating value for the community, the core values behind building strong partnerships with clients are speed, creativity, in-depth knowledge of the players and the evolving environment, transparency, accountability, commitment to results and focus on customers and their needs, professionalism, and compliance.
Our experience in market access for a wide range of healthcare technologies, including innovative medicines and advanced therapies, has enabled us to acquire expertise on a number of issues and therapeutic areas, each time characterized by unique challenges that require a focused approach. We have worked with many companies, both big biopharmaceutical companies and start-ups, demonstrating our ability to adapt to different contexts and offer customized solutions for our clients. With our strong network of strategic partnerships with leading experts in the field, we are able to offer a competitive advantage and unique perspective in market access projects.
Do you have any questions? Write to us. Do you have any questions? Write to us. Do you have any questions? Write to us. Do you have any questions? Write to us. Do you have any questions? Write to us.
CONTACTS
info@morethanaccess.com
Registered office: Via Cesare Manigli, 2 - 20121 Milan
Operational headquarter: Via G. Carducci, 24 – 20123 Milan
Sede Legale:
Via Cesare Mangili, 2 – 20121 Milano
Operational headquarter:
Via G. Carducci, 24 – 20123 Milan
info@morethanaccess.com
